Financing, Equity Capital Markets

CytomX Therapeutics Inc.

01/21
|
$114.9 Million
Piper Sandler served as bookrunner for CytomX Therapeutics, Inc, on a follow-on offering
Sub-Type
Follow-On Offering
Sub-Sector
Biopharma